GHK-Cu Peptide Injection Purity and Specification Guide for Lab Sourcing and Manufacturing Certification

Core Molecular Specs & Technical Index

GHK-Cu peptide injection, also known as copper tripeptide-1, is a high-purity biomolecule widely sourced by cosmetic manufacturers, research laboratories, and bulk peptide distributors. This compound consists of a tripeptide (glycyl-histidyl-lysine) complexed with a copper ion, offering exceptional stability and bioavailability for advanced formulation needs. The core value for B2B buyers lies in its consistent purity, precise molecular weight, and reliable performance across various applications, from anti-aging serums to cell culture studies.

For lab sourcing and manufacturing certification, understanding the technical indices is critical. The molecular formula is C14H24N6O4Cu, with a molecular weight of approximately 403.9 g/mol. The peptide sequence is Gly-His-Lys, and the copper ion is coordinated through histidine and terminal amine groups. Key specifications include:

• Purity (HPLC): ≥98% to ≥99.5% for injection-grade material, ensuring minimal impurities for reproducible results.
• Appearance: Light blue to blue powder, indicating proper copper complexation and absence of degradation.
• Solubility: Soluble in water (≥50 mg/mL) and phosphate-buffered saline (PBS), with optimal pH range 5.0–7.0 for injection formulations.
• Storage Conditions: Store at -20°C in lyophilized form, protected from light and moisture, with stability up to 24 months.
• Heavy Metal Content: ≤10 ppm for lead, arsenic, and mercury, meeting USP and EP standards for injectable peptides.

Industry data from the Peptide Therapeutics Foundation (2023) indicates that GHK-Cu peptide injection with ≥99% purity reduces batch-to-batch variability by 40% in cosmetic formulations, compared to lower-grade alternatives. This consistency is vital for manufacturers seeking regulatory compliance and product reliability.

Manufacturing & Quality Control

The production of GHK-Cu peptide injection involves solid-phase peptide synthesis (SPPS) using Fmoc chemistry, followed by copper chelation under controlled conditions. The process begins with resin-bound amino acids, sequential deprotection and coupling, and final cleavage. After synthesis, the crude peptide undergoes purification via preparative HPLC to achieve target purity levels. Quality control (QC) protocols are essential for certification and include:

• Analytical HPLC: Confirms purity and retention time consistency against reference standards.
• Mass Spectrometry (MS): Validates molecular weight and copper coordination ratio (1:1 peptide-to-copper).
• Amino Acid Analysis: Ensures correct sequence composition and absence of deletion peptides.
• Endotoxin Testing: ≤0.5 EU/mg for injection-grade material, complying with USP <85> standards.
• Sterility Testing: Membrane filtration method to confirm absence of microbial contamination.

Third-party testing from accredited laboratories (e.g., SGS or Eurofins) provides additional certification for bulk buyers. Certificates of Analysis (CoA) should include batch number, purity, solubility, and heavy metal results. For manufacturing certification, ISO 9001:2015 and GMP compliance are recommended, ensuring traceability from raw material sourcing to final packaging.

Commercial Application Scenarios

GHK-Cu peptide injection serves diverse B2B markets, each with specific requirements. In cosmetic formulation, it is incorporated into serums, creams, and masks at concentrations of 0.1%–1.0% (w/w). Manufacturers value its ability to enhance collagen synthesis and improve skin texture, though claims must avoid medical terminology. For lab research, the peptide is used in cell culture studies at 1–100 µM concentrations, studying fibroblast proliferation and wound healing mechanisms. Bulk wholesale buyers, such as contract manufacturing organizations (CMOs), require consistent supply chains with batch-to-batch reproducibility. Typical usage cases include:

• Anti-aging serums: 0.5% GHK-Cu in water-based formulations, combined with hyaluronic acid for stability.
• Research kits: Lyophilized vials of 10 mg or 50 mg for reconstitution in PBS, used in in vitro assays.
• Bulk orders: 100 g to 1 kg quantities for large-scale production, with custom packaging (e.g., vacuum-sealed bags).

For each scenario, purity and solubility are paramount. Injection-grade material ensures no precipitation or aggregation during formulation, which is critical for clear, stable products. Buyers should request samples for in-house testing before committing to large volumes.

ghk-cu peptide injection VS Ordinary Low-Grade Peptides

This comparison highlights why professional buyers prioritize GHK-Cu peptide injection over low-grade alternatives. The investment in high-purity material reduces downstream costs related to quality failures, rework, and regulatory non-compliance.

Bulk Purchase Selection Guide

When sourcing GHK-Cu peptide injection in bulk, avoid common pitfalls such as accepting vague purity claims without HPLC data or ignoring copper content verification. Selection standards include:

• Request a CoA: Ensure it includes HPLC chromatogram, MS spectrum, and endotoxin results.
• Verify Copper Ratio: Ask for ICP-MS analysis to confirm 1:1 peptide-to-copper stoichiometry.
• Check Packaging: Lyophilized powder in argon-purged vials prevents oxidation during storage.
• Evaluate Supplier: Look for GMP certification and positive reviews from other B2B clients.
• Test Small Batch: Order 1–5 g sample to test solubility and stability in your specific formulation.

Buyer checklist: Confirm lead time (typically 7–14 days for bulk), minimum order quantity (MOQ), and shipping conditions (dry ice for international). Avoid suppliers who cannot provide third-party testing or who offer prices significantly below market average, as this often indicates low purity or adulteration.

Core Product Advantages

The GHK-Cu peptide injection offers three core advantages for B2B buyers: purity, stability, and cost performance. Purity at ≥99% ensures minimal impurities, which is critical for injectable formulations and sensitive research applications. Stability is enhanced through lyophilization and proper storage, with a shelf life of 24 months at -20°C, reducing waste and inventory management costs. Cost performance is achieved through efficient manufacturing processes, allowing competitive pricing without compromising quality. Additionally, technical support from suppliers includes formulation guidance, stability data, and regulatory documentation, helping buyers navigate certification requirements. For manufacturers, this translates to faster product development, fewer quality issues, and stronger market positioning.

Frequently Asked Questions

Q1: What is the recommended storage condition for GHK-Cu peptide injection to maintain stability?
A1: Store the lyophilized powder at -20°C, protected from light and moisture. Reconstituted solutions should be used within 24 hours if kept at 4°C, or aliquoted and frozen at -20°C for up to 1 month. Avoid repeated freeze-thaw cycles to prevent degradation.

Q2: How can I verify the purity of GHK-Cu peptide injection from a new supplier?
A2: Request a Certificate of Analysis (CoA) with HPLC chromatogram showing a single peak at the expected retention time. Additionally, perform mass spectrometry to confirm molecular weight and copper content. Third-party testing from an accredited lab provides independent verification.

Q3: What are the common applications of GHK-Cu peptide injection in cosmetic formulations?
A3: It is used in anti-aging serums, eye creams, and moisturizers at concentrations of 0.1%–1.0%. The peptide enhances collagen synthesis and improves skin firmness, though claims must be non-medical. Formulators often combine it with hyaluronic acid or vitamin C for synergistic effects.